HOME >> MEDICINE >> NEWS
Mount Sinai Researchers present findings on treatments for prostate and breast cancer

Researchers from the Department of Radiation Oncology and the Milton and Caroll Petrie Department of Urology at Mount Sinai School of Medicine are presenting findings from ten studies of prostate and breast cancer treatments at the 47th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), October 16-20, 2005, in Denver, Colorado.

The research results being detailed:

  • A higher incidence of ATM gene variants in African American Women. (Lead author: G. Fan)
  • A significant percentage (at seven years minimum) of men with normal pre-treatment sexual function were able to experience a high rate of erectile function as quantified by the IIEF-5 and physician assigned a scoring system. (Lead author: J.A. Cesaretti)
  • Possession of a mutated ATM gene is associated with the development of grade 2 proctitis for patients treated with 125I brachytherapy. (Lead author: J.A. Cesaretti)
  • A specific genetic alteration is predictive for the development of late adverse radiotherapy responses among breast cancer patients treated with adjuvant radiation therapy. (Lead author: A.Y. Ho)
  • Prostate brachytherapy is generally well tolerated and appears to be safe in patients with a history of IBD. (Lead author: C.A. Peters)
  • If biologically effective doses can be achieved, excellent long-term biochemical and local control rates can be realized. (Lead author: R.G. Stock)
  • Overall long term morbidity associated with brachytherapy with or without HT and EBRT is low. (Lead author: N.N. Stone)
  • Insight into patient's erectile function post-brachytherapy can b well-assessed using the Mount Sinai Erectile Function Scale, along with, the International Index of Erectile Function-15. (Lead author: T.M. Zagar)
  • Ultrasound-guided brachytherapy is a reasonable salvage option for patients with biopsy proven biochemical recurrence following definitive external beam radiation therapy. (Lead author:
    '"/>


Contact: Mount Sinai Press Office
newsmedia@mssm.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
18-Oct-2005


Page: 1 2

Related medicine news :

1. New breakthrough treatment for spinal cancer patients at Mount Sinai
2. Mount Sinai and EXACT Sciences announce study results on study stool DNA testing for colon cancer
3. Wiley to assume publication of Mount Sinai Journal of Medicine
4. Mount Sinai researcher finds drinking water safe to drink
5. The Mount Sinai Medical Center recognized for excellence in bariatric surgery
6. Mount Sinai Global Health Center receives $1M grant
7. Mount Sinai School of Medicine receives prestigious AAMC Grant for Chronic Illness Care education
8. Mount Sinai and YAI/NIPD Network join forces to further quality of care for people with autism
9. Mount Sinai launches combination therapy trial to treat Relapsing-Remitting Multiple Sclerosis
10. CNIC commits 5 million Euros to the Mount Sinai School of Medicine
11. Mount Sinai expands cutting-edge molecular testing

Post Your Comments:
(Date:3/31/2015)... NC (PRWEB) March 31, 2015 Smartlink ... engagement technology, today announced that Chris Lynch, Managing ... Annual Southeast Venture Conference (SEVC) this week in Charlotte, ... technology firms in the southeast region and provides these ... capitalists and private equity investors. , This year’s ...
(Date:3/31/2015)... 2015 These two automakers will address ... ecosystem. They will highlight a shift that has become ... insurance a business proposition for the insurance carriers alone. ... the opportunities that lie in store for them. ... automakers are now alive to their own involvement in ...
(Date:3/31/2015)... MA and Willimantic, CT (PRWEB) March 31, 2015 ... the word about the settlement of a nationwide ... No. 5:11-CV-17, District of Vermont) and seeking to ... to patients who did not meet an “improvement ... Medicare Advocacy are releasing a video conversation with ...
(Date:3/31/2015)... 2015 April is Parkinson’s disease Awareness Month ... announce 30 Days, 30 Ways to Make a Difference. ... that will offer a new action each day throughout April ... who battle this disease. , Every nine minutes ... alone nearly 5,000 individuals in this country will learn they ...
(Date:3/31/2015)... Azilen Technologies adds yet another ... Development Company’ award at GESIA 2015. The firm earned ... Annual Award GESIA 2015. This marks Azilen’s second triumph ... It previously won the ‘Best Product Innovation’ award at ... product development, enterprise mobility solutions and open source technologies. ...
Breaking Medicine News(10 mins):Health News:Smartlink Mobile Chosen to Present at Southeast Venture Conference 2Health News:TU-Automotive: Fiat and Renault-Nissan at the Centre of a Motor Insurance Evolution 2Health News:Mythbusters: Harmony Healthcare International and Center for Medicare Advocacy Team-Up to Dispel Myths On Medicare Coverage for Maintaining a Patient’s Condition 2Health News:Mythbusters: Harmony Healthcare International and Center for Medicare Advocacy Team-Up to Dispel Myths On Medicare Coverage for Maintaining a Patient’s Condition 3Health News:Mythbusters: Harmony Healthcare International and Center for Medicare Advocacy Team-Up to Dispel Myths On Medicare Coverage for Maintaining a Patient’s Condition 4Health News:Join The American Parkinson Disease Association to Commemorate April Parkinson's Awareness Month 2Health News:Join The American Parkinson Disease Association to Commemorate April Parkinson's Awareness Month 3Health News:Azilen Technologies Receives ‘Best Product Development Company’ Award at GESIA 2015 2
(Date:3/31/2015)... 31, 2015 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or ... quality medical marijuana products and a licensed producer ("LP") ... Regulations ( Canada ) ("MMPR"), is pleased ... Corporation of the District of Saanich ... premises which now allows for commercial distribution of medical ...
(Date:3/31/2015)... 31, 2015 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... Hydrochloride 150mg, 225mg and 300mg oral tablets, indicated for ... US market for Propafenone Hydrochloride 150mg, 225mg and 300mg ... Arthur S. Przybyl , President and ... the launch of our fourth product from the portfolio ...
(Date:3/31/2015)... DUBLIN , Mar. 27, 2015 Research ... announced the addition of the "European Laboratory ... Information System), by Type (Clinical Pathology Laboratory Information ... to 2019" report to their offering. ... estimated to grow at a CAGR of 7.6% ...
Breaking Medicine Technology:T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 2European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 3
Cached News: